# FDA Inspection 1276853 - Biomat USA, Inc. - July 16, 2025

Source: https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/7066a7c2-dcf1-4d63-be53-8e056697b332
Source feed: FDA_Inspections

> FDA Inspection 1276853 for Biomat USA, Inc. on July 16, 2025. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1276853
- Company Name: Biomat USA, Inc.
- Inspection Date: 2025-07-16
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1276853 - 2025-07-16](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/f2552092-13ea-487f-bac6-69f7cbcd234d)
- [FDA Inspection 1012620 - 2017-05-18](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/00421f29-f674-443e-92d8-ce88752f0d02)
- [FDA Inspection 808880 - 2012-11-30](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/6cba495c-d0af-47cd-be6e-db9e12969dd2)

Company: https://www.keypedia.com/companies/biomat-usa-inc/6f792c76-db9b-4872-9deb-389abdb717c4

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d